Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | ENPP3 | O14638 | 2/20 | 0.32 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.32 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.31 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.31 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KDM2B | Q8NHM5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21135767 | 0.88 | ALDH1A1 (0.37) | ALDH1A1NAAAENPP3ENPP1ENPP2 | |
| SCHEMBL21136378 | 0.86 | SMN1; SMN2 (0.33) | ALDH1A1ENPP3ENPP1ENPP2SMN1; SMN2 | |
| SCHEMBL21136611 | 0.82 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2ADRB2ADRB1ADRB3 | |
| SCHEMBL21136608 | 0.81 | ALDH1A1 (0.34) | ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL21136607 | 0.80 | EPHX2 (0.36) | ALDH1A1NAAAENPP3ENPP1ENPP2 | |
| SCHEMBL21136603 | 0.75 | CES2 (0.33) | SMN1; SMN2KMT2A | |
| SCHEMBL21136609 | 0.74 | EPHX1 (0.33) | ALDH1A1KMT2AMEN1 | |
| SCHEMBL21136606 | 0.74 | SMN1; SMN2 (0.34) | ALDH1A1TSHRSMN1; SMN2ADRB2ADRB1 | |
| SCHEMBL21136388 | 0.74 | NAAA (0.37) | ALDH1A1NAAAENPP3ENPP1ENPP2 | |
| SCHEMBL16020242 | 0.73 | ADRB2 (0.37) | ALDH1A1SMN1; SMN2ADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190196326-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190196326-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE | RER1, ACTR5, RAD51 | ALDH1A1 1556/4885NAAA 1615/4885ENPP3 684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.